Closed tender · India · Public tender
Custom Bid for Services - API Synthesis, GLP toxicology and safety Pharmacological Studies and Phas
Ministry of Defence in India invited bids for “Custom Bid for Services - API Synthesis, GLP toxicology and safety Pharmacological Studies and Phas”. Bids closed on 12 October 2026, 12:00 IST. Reference: GEM/2026/B/8038644.
The tender in brief
A 2-year 10-month contract for API synthesis, GLP toxicology and Phase-1 clinical trial of DCM, for drug development service providers.
The Ministry of Defence (DRDO) requires a service provider to synthesise an active pharmaceutical ingredient (API), conduct GLP toxicology and safety pharmacology studies, and run a Phase-1 clinical trial of DCM. The contract is for 2 years and 10 months, performed as a lump-sum project at DRDE Gwalior. Bids are evaluated on total value, with a two-packet system and reverse auction.
Who can win it
- Must meet the experience criteria specified in the bid
- Must meet the bidder turnover criteria specified in the bid
Key facts
- Contract period
- 2 years and 10 months
- How bids are judged
- Total value wise evaluation, two-packet bid, reverse auction among technically qualified bidders except H1
- Published
- 16 Sep 2026
- Reference
- GEM/2026/B/8038644
Public data: Government e-Marketplace, Government of India. · Sources & licences